Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Tribune France.
Press releases published on June 3, 2025
GLX Analytix Appoints Leading Diagnostic/Biomarker Expert as Chief Scientific Officer and Unveils Groundbreaking Study
EIN Presswire
·
June 3, 2025
Award-winning startup advancing biologically informed neuropsychiatric diagnostics adds Dr. Andreas Jeromin as consulting CSO to support growth. SILICON VALLEY, CA, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- GLX® Analytix(GLX), an award-winning …
Top 5 Life Sciences Manufacturer Selects On Time Edge to Deliver Global Digital Strategy
EIN Presswire
·
June 3, 2025
Digital strategy to become company’s blueprint for worldwide implementation to reinforce and extend global bio-manufacturing leadership. DENVER, CO, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- On Time Edge, a leading provider of digital …
Allotex Appoints Dirk Muehlhoff to its Board of Directors
EIN Presswire
·
June 3, 2025
Seasoned ophthalmic industry leader joins Allotex Board to strengthen strategic positioning and support global scale-up of its presbyopia correction platform. MILANO, ITALY, June 3, 2025 /EINPresswire.com/ -- Allotex group, a leader in natural tissue- …
MSCopilot® receives CE marking under the European Union Medical Device Regulation (EU MDR) 2017/745
EIN Presswire
·
June 3, 2025
A major milestone for the digital monitoring of people living with multiple sclerosis PARIS, FRANCE, FRANCE, June 3, 2025 /EINPresswire.com/ -- On the occasion of World Multiple Sclerosis Day, Ad Scientiam announced that MSCopilot®, its class IIa …
Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector
GlobeNewswire
·
June 3, 2025
ASCO: new Sarclisa data support subcutaneous administration with on-body injector New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with …
Communiqué de presse : ASCO : de nouvelles données sur le Sarclisa appuient l’administration sous-cutanée avec un injecteur sur le corps
GlobeNewswire
·
June 3, 2025
ASCO : de nouvelles données sur le Sarclisa appuient l’administration sous-cutanée avec un injecteur sur le corps De nouvelles données provenant de deux études cliniques ont démontré que le Sarclisa administré par voie sous-cutanée via un injecteur …
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
GlobeNewswire
·
June 3, 2025
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare diseases Under regulatory review in the US, the EU, and China in immune thrombocytopenia Paris, June 3, 2025. The US …
Communiqué de presse : Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de la drépanocytose
GlobeNewswire
·
June 3, 2025
Le rilzabrutinib obtient la désignation de médicament orphelin aux États-Unis pour le traitement de la drépanocytose Quatrième désignation de médicament orphelin pour le rilzabrutinib dans les maladies rares En cours d’examen réglementaire aux États-Unis, …